{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:54:27Z","timestamp":1782168867670,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cmi.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T12:18:36Z","timestamp":1533989916000},"page":"620-622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Contraindicated drug\u2013drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care setting in the United States"],"prefix":"10.1016","volume":"25","author":[{"given":"K.","family":"Eljaaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Al-Tawfiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Patanwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jac\/dkt301","article-title":"Antibiotic prescribing for adults in ambulatory care in the USA, 2007\u201309","volume":"69","author":"Shapiro","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cger.2012.01.001","article-title":"Factors leading to excessive polypharmacy","volume":"28","author":"Hovstadius","year":"2012","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.cmi.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cger.2012.01.002","article-title":"Polypharmacy, adverse drug reactions, and geriatric syndromes","volume":"28","author":"Shah","year":"2012","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.cmi.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/14740338.6.6.695","article-title":"Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable","volume":"6","author":"Salazar","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cmi.2018.08.002_bib5","unstructured":"Centers for Disease Control and Prevention. Ambulatory health care data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd.htm."},{"key":"10.1016\/j.cmi.2018.08.002_bib6","unstructured":"National Center for Health Statistics. Ambulatory health care data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/."},{"key":"10.1016\/j.cmi.2018.08.002_bib7","unstructured":"Lexi-Drugs. Lexicomp. Riverwoods, IL: Wolters Kluwer Health. Available at: http:\/\/online.lexi.com."},{"key":"10.1016\/j.cmi.2018.08.002_bib8","unstructured":"Micromedex Solutions. Ann Arbor, MI: Truven Health Analytics. Available at: http:\/\/www.micromedexsolutions.com."},{"key":"10.1016\/j.cmi.2018.08.002_bib9","unstructured":"National Center for Health Statistics. Reliability of estimates. Available at: https:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_estimation_reliability.htm."},{"key":"10.1016\/j.cmi.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2004.07.080","article-title":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors","volume":"94","author":"Jacobson","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cmi.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9236(98)90151-5","article-title":"Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations","volume":"64","author":"Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cmi.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11317220-000000000-00000","article-title":"A\u00a0proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labeling","volume":"48","author":"Hisaka","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2018.08.002_bib13","first-page":"1","article-title":"An updated review of interactions of statins with antibacterial and antifungal agents","volume":"3","author":"Eljaaly","year":"2017","journal-title":"J\u00a0Transl Sci"},{"key":"10.1016\/j.cmi.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00002018-199717040-00006","article-title":"Drug-induced cardiac arrhythmias: incidence, prevention and management","volume":"17","author":"Doig","year":"1997","journal-title":"Drug Saf"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18305743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18305743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:21:25Z","timestamp":1761117685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18305743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1198743X18305743"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.08.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraindicated drug\u2013drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care setting in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}